Validity of Luminex and Enzyme-Linked Immunosorbent Assay Measuring Vascular Endothelial Growth Factor and Six Cytokines Quantitatively in Bone Marrow Aspiration Supernatant: Pilot Study

Authors
Cho, Chi-HyunPark, Min-Chul
Issue Date
2022-07
Publisher
ASSOC CLINICAL SCIENTISTS
Citation
ANNALS OF CLINICAL AND LABORATORY SCIENCE, v.52, no.4, pp.663 - 676
Abstract
Objective. Vascular endothelial growth factor (VEGF) and other cytokines have been reported to be implicated in the molecular pathogenesis of hematologic malignancy. However, a quantitative measure-ment of VEGF and related cytokines is necessary to reflect the real situation in the bone marrow (BM). Currently, no such quantitative assays exist for use in the BM supernatant as their concentrations have not been previously validated in the BM. Here we performed linearity and recovery tests to quantitatively mea-sure the concentrations of VEGF and six related cytokines in the BM. Method. A total of 24 BM superna-tant samples were collected from patients who underwent a BM examination for hematological malignan-cies. The levels of VEGF and six cytokines -granulocyte colony-stimulating factor (G-CSF), interferon -(3 (INF -(3), interleukin (IL)-1(3, IL-6, IL-17A, and tumor necrosis factor-alpha (TNF-alpha) -were measured using Luminex assay and enzyme-linked immunosorbent assay. Percentage recovery and linearity were calculated, with the acceptable range being 80-120%. The undiluted and diluted (1:2, 1:4, and 1:8) concentrations of VEGF and the six cytokines in 24 spiked and unspiked BM supernatant samples and controls were also measured. Results. For VEGF, both assays passed the percentage recovery and linearity tests; wherein the undiluted and all diluted concentrations of VEGF in all six unspiked BM samples showed linearity parallel to those of VEGF in spiked BM samples and controls. For the other six cytokines, both assays did not pass the percentage recovery and linearity tests, with the undiluted and diluted concentrations in all seventeen unspiked BM samples (except G-CSF in one sample) showing a lack of parallelism to those in spiked BM samples and controls. Conclusions. Quantitative VEGF measurement in real BM specimens was validated using both Luminex assay and ELISA. All six cytokines, except for VEGF, whether undiluted or diluted, could not be accurately measured in the BM supernatants, indicating the presence of inhibitors to the ana-lytes. Quantitative measurement of VEGF-related cytokines in the BM will have to be validated in further studies with more samples.
Keywords
VEGF; CANCER; bone marrow; VEGF; cytokine; hematological malignancy; Luminex; ELISA
ISSN
0091-7370
URI
https://pubs.kist.re.kr/handle/201004/114865
DOI
10.1478/annals.0235
Appears in Collections:
KIST Article > 2022
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE